LabGenomics has recorded no insider trading activity within the last three months. The most recent transaction occurred on December 26, 2017, when a director sold 7,612 shares valued at approximately 74,308.34. Given the significant time elapsed since this event, current market conditions remain unrelated to historical executive movements.